Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?

doi:10.3748/wjg.v25.i29.3929

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 29

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8036)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

861

WORD

255

HTML

4508

Figures (1-2)

159

Sum=5783

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

869

Download

1379

Sum=2248

Aug 7, 2019 (publication date) through May 1, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Aug 7, 2019; 25(29): 3929-3940
Published online Aug 7, 2019. doi: 10.3748/wjg.v25.i29.3929

Open in New Tab Full Size Figure Download Figure

Figure 1 Risk factors and their association with hepatocellular carcinoma in patients with chronic hepatitis C virus infection. SVR: Sustained virologic response.

Open in New Tab Full Size Figure Download Figure

Figure 2 Our suggested algorithm for hepatitis C virus patients after antiviral therapy. A: Suggested algorithm for hepatitis C virus patients [without previous hepatocellular carcinoma (HCC)] after treatment with direct-acting antiviral according to their risk to develop HCC and recommended surveillance strategy; B: Our surveillance strategy for HCC recurrence after DAA therapy. SVR: Sustained virologic response; AFP: Alpha-fetoprotein; CT: Computed tomography; MRI: Magnetic resonance imaging; HCC: Hepatocellular carcinoma.

Citation: Meringer H, Shibolet O, Deutsch L. Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm? World J Gastroenterol 2019; 25(29): 3929-3940
URL: https://www.wjgnet.com/1007-9327/full/v25/i29/3929.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i29.3929